Centrus Energy (LEU)
NYSE:LEU
Want to see LEU full AI Analyst Report?
Top Page
Centrus Energy
(NYSE:LEU)
Select Model
Select Model
Rating:57Neutral
Price Target:
$239.00
▲(17.37% Upside)
Action:ReiteratedDate:05/07/26
The score is held back primarily by mixed financial quality—especially inconsistent cash-flow conversion and elevated leverage—despite continued profitability. The latest earnings call was a meaningful positive (raised guidance, large backlog, strong liquidity), and technicals are moderately supportive, but valuation remains a key headwind given the very high P/E and no dividend support.
Positive Factors
Large multi-year backlog ($3.9B through 2040)
A $3.9B contracted backlog delivers multi-year revenue visibility and reduces reliance on spot sales. This underpins production and capital planning across Piketon/Oak Ridge, supports predictable cash flows for the build-out, and materially de-risks near-to-mid-term revenue execution.
Negative Factors
Elevated leverage (debt rose to ~$1.21B; debt/equity ~1.6x)
Higher absolute debt and a ~1.6x debt/equity ratio constrain financial flexibility during a capital-heavy build-out. Elevated leverage increases interest and covenant exposure, reducing room for operational setbacks and making the company more sensitive to funding or milestone delays in the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Large multi-year backlog ($3.9B through 2040)
A $3.9B contracted backlog delivers multi-year revenue visibility and reduces reliance on spot sales. This underpins production and capital planning across Piketon/Oak Ridge, supports predictable cash flows for the build-out, and materially de-risks near-to-mid-term revenue execution.
Read all positive factors
Centrus Energy (LEU) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$4.06B
Dividend YieldN/A
Average Volume (3M)755.10K
Price to Earnings (P/E)85.8
Beta (1Y)1.73
Revenue Growth-4.05%
EPS Growth-48.51%
CountryUS
Employees322
SectorEnergy
Sector Strength52
IndustryUranium
Share Statistics
EPS (TTM)4.38
Shares Outstanding18,952,387
10 Day Avg. Volume819,858
30 Day Avg. Volume755,100
Financial Highlights & Ratios
PEG Ratio-15.73
Price to Book (P/B)5.70
Price to Sales (P/S)9.72
P/FCF Ratio139.35
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue7.22
Enterprise Value/Gross Profit27.57
Enterprise Value/Ebitda29.51
Forecast
1Y Price Target
$274.64Price Target Upside34.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)2.74
Revenue Forecast (FY)$459.36M
Centrus Energy Business Overview & Revenue Model
Company Description
Centrus Energy Corp. supplies nuclear fuel and services for the nuclear power industry in the United States, Japan, Belgium, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LE...
How the Company Makes Money
Centrus primarily makes money by selling nuclear fuel products and providing nuclear fuel-cycle services under customer contracts. A key revenue stream is the sale of low-enriched uranium (LEU) to nuclear power customers, typically structured thro...
Centrus Energy Earnings Call Summary
Earnings Call Date:May 05, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 11, 2026
Earnings Call Sentiment Positive
The call presents a predominantly constructive outlook driven by a large contracted backlog ($3.9B), a major DOE HALEU award, strong cash reserves ($1.9B), strategic partnerships, identified cost savings (~$300M), and an upward revision to 2026 revenue guidance. These positives are tempered by near-term profitability pressure from increased expansion-related (advanced technology) costs, a meaningful year-over-year decline in GAAP net income and EPS, reduced LEU/SWU volumes in the quarter, and some execution/timing uncertainty around pending government awards and project milestones. Overall, the operational momentum, funding runway, and strategic initiatives outweigh the transitory cost and timing headwinds, supporting a favorable outlook while acknowledging execution risk during build-out.Positive Updates
Revenue and Profitability (Q1 2026)
Reported Q1 revenue of $76.7 million, up $3.6 million (5%) year-over-year; gross profit of $31.5 million (TTM gross profit $116.1 million); operating income of $0.8 million; net income of $10.0 million; diluted EPS $0.45. Introduced adjusted metrics: adjusted net income $23.5 million and adjusted diluted EPS $1.05.
Negative Updates
LEU Segment Pressure and SWU Volume Decline
LEU segment revenue declined to $44.6 million in Q1, a 13% decrease year-over-year. SWU revenue decreased due to a 47% decline in SWU volume sold, partially offset by a 52% increase in average SWU price.
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue and Profitability (Q1 2026)
Reported Q1 revenue of $76.7 million, up $3.6 million (5%) year-over-year; gross profit of $31.5 million (TTM gross profit $116.1 million); operating income of $0.8 million; net income of $10.0 million; diluted EPS $0.45. Introduced adjusted metrics: adjusted net income $23.5 million and adjusted diluted EPS $1.05.
Read all positive updates
Company Guidance
Centrus reaffirmed its 2026 operational plan while raising full-year revenue guidance to $450–$500 million (from $425–$475M) and reiterated targets to finalize contracts with 100% of critical partners, release a certified-for-construction package, and limit total capital spend to $350–$500 million; workforce targets were increased to at least 100 net new hires at Oak Ridge and over 100 net new hires in Piketon (up from 50+). The company closed Q1 with a $3.9 billion backlog through 2040 (LEU $3.1B — including $700M broker-dealer and $2.4B contingent under definitive agreements — plus $0.8B in Technical Solutions), noted a $900 million DOE HALEU award (potential to exceed $1B) supporting a 12 metric‑ton HALEU build, and reported it has contractually produced >1.6 metric tons of HALEU UF6; Centrus finished the quarter with $1.9 billion of unrestricted cash (and roughly $2.8 billion of near‑term funding when including the $900M award on milestones) and a trailing‑12‑month revenue run rate of $452.3 million.Centrus Energy Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
54
Neutral
Cash Flow
41
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 448.70M | 442.00M | 320.20M | 293.80M | 298.30M |
| Gross Profit | 117.50M | 111.50M | 112.10M | 117.90M | 114.50M |
| EBITDA | 109.80M | 86.50M | 92.90M | 77.90M | 144.60M |
| Net Income | 77.80M | 73.20M | 84.40M | 52.20M | 175.00M |
Balance Sheet | |||||
| Total Assets | 2.45B | 1.10B | 796.20M | 705.50M | 572.40M |
| Cash, Cash Equivalents and Short-Term Investments | 1.96B | 701.40M | 201.20M | 179.90M | 193.80M |
| Total Debt | 1.21B | 547.20M | 177.10M | 169.80M | 134.20M |
| Total Liabilities | 1.68B | 937.60M | 763.90M | 779.60M | 714.30M |
| Stockholders Equity | 765.10M | 161.40M | 32.30M | -74.10M | -141.90M |
Cash Flow | |||||
| Free Cash Flow | 31.30M | 32.90M | 7.50M | 19.90M | 48.80M |
| Operating Cash Flow | 51.00M | 37.00M | 9.10M | 20.60M | 50.00M |
| Investing Cash Flow | -19.70M | -4.10M | -1.60M | -700.00K | -1.20M |
| Financing Cash Flow | 1.22B | 437.10M | 13.90M | -4.30M | -9.90M |
Centrus Energy Technical Analysis
Neutral
203.63
Price Trends
202.05
Positive
238.35
Negative
251.48
Negative
Market Momentum
-2.23
Negative
54.92
Neutral
83.45
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LEU, the sentiment is Neutral. The current price of 203.63 is above the 20-day moving average (MA) of 187.86, above the 50-day MA of 202.05, and below the 200-day MA of 251.48, indicating a neutral trend. The MACD of -2.23 indicates Negative momentum. The RSI at 54.92 is Neutral, neither overbought nor oversold. The STOCH value of 83.45 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for LEU.
Centrus Energy Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $8.49B | 5.33 | 15.91% | 4.32% | -4.16% | -23.51% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
59 Neutral | $6.93B | 84.88 | 1.45% | 3.24% | -1.33% | -84.10% | |
57 Neutral | $4.06B | 85.81 | 10.71% | ― | -4.05% | -48.51% | |
56 Neutral | $5.83B | ― | -13.16% | ― | 21.95% | 29.05% | |
55 Neutral | $7.64B | -149.77 | -7.09% | ― | -69.78% | -15.01% | |
54 Neutral | $723.14M | -8.43 | -76.17% | ― | -19.28% | -20.87% |
* Energy Sector Average
LEU
Centrus Energy
206.30
112.70
120.41%
FRO
Frontline
38.12
21.87
134.56%
NOV
NOV
19.30
7.28
60.58%
URG
UR-Energy
1.82
1.11
156.34%
UEC
Uranium Energy
15.59
9.89
173.51%
UUUU
Energy Fuels
23.35
18.59
390.55%
Centrus Energy Corporate Events
Business Operations and Strategy
Centrus Advances Piketon Uranium Plant Expansion With New Contractor
Positive
Apr 20, 2026
On April 16, 2026, Centrus subsidiary American Centrifuge Operating signed a construction contract with Ohio-based Geiger Brothers to serve as primary construction contractor for the multi-billion-dollar expansion of its uranium enrichment plant i...
Business Operations and StrategyRegulatory Filings and Compliance
Centrus Energy Updates Bylaws, Tightens Governance and Disputes
Neutral
Mar 16, 2026
On March 10, 2026, Centrus Energy Corp.’s board adopted Fourth Amended and Restated Bylaws that clarify its stockholder voting standard without changing the substantive requirements, aligning the language with the company’s existing pr...
Business Operations and Strategy
Centrus Partners With Fluor to Expand Uranium Enrichment
Positive
Feb 11, 2026
On February 9, 2026, Centrus subsidiary American Centrifuge Operating entered an engineering, procurement and construction agreement with Fluor Federal Services to design, build and commission a commercial uranium enrichment facility expansion in ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.